Format

Send to

Choose Destination
Nat Commun. 2019 Mar 8;10(1):1136. doi: 10.1038/s41467-019-09006-2.

CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations.

Author information

1
Univ. Bordeaux, 33000, Bordeaux, France.
2
INSERM U1035, Biotherapy of genetic diseases, inflammatory disorders and cancers, 33000, Bordeaux, France.
3
Biochemistry Laboratory, CHU Bordeaux, 33000, Bordeaux, France.
4
Medical genetic laboratory, CHU Bordeaux, 33000, Bordeaux, France.
5
UMR 5320, INSERM U1212, ARNA Laboratory, 33000, Bordeaux, France.
6
Vectorology Platform, 33000, Bordeaux, France.
7
INSERM U1218, ACTION, 33000, Bordeaux, France.
8
Laboratory of excellence, GR-Ex, Imagine institute, 75015, Paris, France.
9
Univ. Bordeaux, 33000, Bordeaux, France. francois.moreau-gaudry@u-bordeaux.fr.
10
INSERM U1035, Biotherapy of genetic diseases, inflammatory disorders and cancers, 33000, Bordeaux, France. francois.moreau-gaudry@u-bordeaux.fr.
11
Biochemistry Laboratory, CHU Bordeaux, 33000, Bordeaux, France. francois.moreau-gaudry@u-bordeaux.fr.
12
Vectorology Platform, 33000, Bordeaux, France. francois.moreau-gaudry@u-bordeaux.fr.
13
Laboratory of excellence, GR-Ex, Imagine institute, 75015, Paris, France. francois.moreau-gaudry@u-bordeaux.fr.

Abstract

CRISPR-Cas9 is a promising technology for genome editing. Here we use Cas9 nuclease-induced double-strand break DNA (DSB) at the UROS locus to model and correct congenital erythropoietic porphyria. We demonstrate that homology-directed repair is rare compared with NHEJ pathway leading to on-target indels and causing unwanted dysfunctional protein. Moreover, we describe unexpected chromosomal truncations resulting from only one Cas9 nuclease-induced DSB in cell lines and primary cells by a p53-dependent mechanism. Altogether, these side effects may limit the promising perspectives of the CRISPR-Cas9 nuclease system for disease modeling and gene therapy. We show that the single nickase approach could be safer since it prevents on- and off-target indels and chromosomal truncations. These results demonstrate that the single nickase and not the nuclease approach is preferable, not only for modeling disease but also and more importantly for the safe management of future CRISPR-Cas9-mediated gene therapies.

PMID:
30850590
PMCID:
PMC6408493
DOI:
10.1038/s41467-019-09006-2
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center